Responses of Total and Quiescent Cell Populations in Solid Tumors to Boron and Gadolinium Neutron Capture Reaction Using Neutrons with Two Different Energy Spectra
Authors:
- 1 January 1998
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 89 (1) , 81-88
Abstract
In neutron capture therapy, whose effectiveness depends on the tumor distribution of neutron capture compound and the neutron energy distribution, controlling quiescent tumor cells with clonogenic potential is critical for therapeutic gain, as is the case in conventional radio‐ and chemotherapy. Tumor‐bearing mice were continuously given 5‐bromo‐2′‐deoxyuridine (BrdU) to label all proliferating cells. After administration of sodium borocaptate‐10B (BSH), dl‐p‐boronophenylalanine‐10B (BPA) or gadodiamide hydrate (Omniscan), the tumors were irradiated with neutrons of different cadmium (Cd) ratio, and then isolated and incubated with cytochalasin‐B (a cytokinesis blocker). The micronucleus (MN) frequency in cells without BrdU labeling (quiescent cells) was determined using immunofluorescence staining for BrdU, and that for total cells was obtained from tumors not pretreated with BrdU. Without drugs, quiescent cells showed lower MN frequencies than total cells, but neutron irradiation reduced gamma‐ray sensitivity difference between the two. Relative biological effectiveness (RBE) of neutrons compared with gamma‐rays was greater in quiescent cells than in total cells, and low Cd ratio neutrons tended to exhibit large RBE values. With neutron capture compounds, MN frequency for each cell population was increased, especially when high Cd ratio neutrons were used. BPA increased the MN frequency for total cells to a greater extent than BSH. However, the sensitivity of quiescent cells treated with BPA was lower than that in BSH‐treated quiescent cells. This tendency was clearly observed in high Cd ratio neutrons. Omniscan only slightly increased the MN frequency in both cell populations, compared with irradiation alone, without drugs. From the viewpoint of increasing the quiescent cell sensitivity, tumors should be irradiated with high Cd ratio neutrons after BSH administration.Keywords
This publication has 20 references indexed in Scilit:
- Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: Its relation to quiescent cell population and tumor cure in neutron capture therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Boron Neutron Capture Therapy of Brain Tumors: Past History, Current Status, and Future PotentialCancer Investigation, 1996
- Astro research fellowship: Apoptosis as a predictor of tumor response to radiation in Stage IB cervical carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Cell survival measurements in an argon, aluminium and sulphur filtered neutron beam: a comparison with 24 keV neutrons and relevance to boron neutron capture therapyBritish Journal of Radiology, 1994
- Design and Preparation of Ethyl Cellulose Microcapsules of Gadopentetate Dimeglumine for Neutron-Capture Therapy Using the Wurster Process.Chemical and Pharmaceutical Bulletin, 1993
- Production of chromosome aberrations, micronuclei, and sister-chromatid exchanges by 24-keV epithermal neutrons in human G0 lymphocytesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1989
- The problem of the quiescent cancer cellAdvances in Enzyme Regulation, 1989
- Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdRInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1984
- Kerma Factors for Neutron Energies below 30 MeVRadiation Research, 1980
- Collective and two-quasiparticle states in 158Gd observed through study of radiative neutron capture in 157GdNuclear Physics A, 1978